Oncolytic adenovirus-induced autophagy: Tumor-suppressive efect and molecular basis

Acta Medica Okayama

Volumn 67, Issue 6, 2013, Pages 333-342

  Tazawa, Hiroshi ^a,b   Kagawa, Shunsuke ^b   Fujiwara, Toshiyoshi ^b  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Autophagy; E2F1; MicroRNA; Oncolytic adenovirus

Indexed keywords

E1A PROTEIN; E1B PROTEIN; E2F1 PROTEIN, HUMAN; MICRORNA; TRANSCRIPTION FACTOR E2F1; VIRUS PROTEIN;

ADENOVIRUS; APOPTOSIS; AUTOPHAGY; CELL DEATH; HUMAN; NEOPLASM; ONCOLYTIC VIROTHERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ADENOVIRUS E1B PROTEINS; ADENOVIRUS E4 PROTEINS; APOPTOSIS; AUTOPHAGY; CELL DEATH; E2F1 TRANSCRIPTION FACTOR; HUMANS; MICRORNAS; NEOPLASMS; ONCOLYTIC VIROTHERAPY;

EID: 84891298094     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Mizushima N and Komatsu M. Autophagy. renovation of cells and tissues. Cell (2011) 147. 728-741
2. Sato K, Tsuchihara K, Fujii S, Sugiyama M, Goya T, Atomi Y. Ueno T, Ochiai A and Esumi H. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res (2007) 67. 9677-9684
3. Hu YL, DeLay M, Jahangiri A, Molinaro AM, Rose SD, Carbonel WS and Aghi MK. Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res (2012) 72. 1773-1783.
4. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T and Thompson CB. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell (2005) 120. 237-248.
5. Kudchodkar SB and Levine B. Viruses and autophagy. Rev Med Virol (2009) 19. 359-378.
6. Oh JE and Lee HK. Modulation of pathogen recognition by autophagy. Front Immunol (2012) 3. 44.
7. Russell SJ, Peng KW and Bell JC. Oncolytic virotherapy. Nat Biotechnol (2012) 30. 658-670.
8. Ito H, Aoki H, Kuhnel F, Kondo Y, Kubicka S, Wirth T, Iwado E. Iwamaru A, Fujiwara K, Hess KR, Lang FF, Sawaya R and Kondo S. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst (2006) 98 625-636.
9. Jiang H, Gomez-Manzano C, Aoki H, Alonso MM, Kondo S. McCormick F, Xu J, Kondo Y, Bekele BN, Colman H, Lang FF and Fueyo J. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells. role of autophagic cell death. J Natl Cancer Inst (2007) 99. 1410-1414.
10. Ulasov IV, Tyler MA, Zhu ZB, Han Y, He TC and Lesniak MS. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of bed in-dependent autophagy. Int J Oncol (2009) 34. 729-742
11. Kawashima T, Kagawa S, Kobayashi N, Shirakiya Y, Umeoka T. Teraishi F, Taki M, Kyo S, Tanaka N and Fujiwara T. Telomerase-specific replication-selective virotherapy for human cancer. Clin Cancer Res (2004) 10. 285-292.
12. Endo Y, Sakai R, Ouchi M, Onimatsu H, Hioki M, Kagawa S. Uno F, Watanabe Y, Urata Y, Tanaka N and Fujiwara T. Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation. Oncogene (2008) 27. 2375-2381.
13. Tazawa H, Yano S, Yoshida R, Yamasaki Y, Sasaki T. Hashimoto Y, Kuroda S, Ouchi M, Onishi T, Uno F, Kagawa S. Urata Y and Fujiwara T. Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis. Int J Cancer (2012) 131 2939-2950.
14. Hasei J, Sasaki T, Tazawa H, Osaki S, YamakawaY, Kunisada T. Yoshida A, Hashimoto Y, Onishi T, Uno F, Kagawa S, Urata Y. Ozaki T and Fujiwara T. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells. Mol Cancer Ther (2013) 12. 314-325.
15. Yokoyama T, Iwado E, Kondo Y, Aoki H, Hayashi Y, Georgescu MM, Sawaya R, Hess KR, Mills GB, KawamuraH, Hashimoto Y. Urata Y, Fujiwara T and Kondo S. Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells. Gene Ther (2008) 15. 1233-1239.
16. Ulasov IV, Sonabend AM, Nandi S, Khramtsov A, Han Y and Lesniak MS. Combination of adenoviral virotherapy and temozolo-mide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo. Br J Cancer (2009) 100. 1154-1164.
17. . Kondo S, Gomez-Manzano C and Fueyo J. Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death. Mol Ther (2008) 16. 487-493.
18. Jiang H, White EJ, Rios-Vicil CI, Xu J, Gomez-Manzano C and Fueyo J. Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J Virol (2011) 85. 4720-4729.
19. Piya S, White EJ, Klein SR, Jiang H, McDonnell TJ, Gomez-Manzano C and Fueyo J. The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells. PLoS One (2011) 6. e29467.
20. Rajecki M, af Hallstrom T, Hakkarainen T, Nokisalmi P. Hautaniemi S, Nieminen Al, Tenhunen M, Rantanen V, Desmond RA, Chen DT, Guse K, Stenman UH, Gargini R, Kapanen M Klefstrom J, Kanerva A, Pesonen S, Ahtiainen L and Hemminki. A Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation. Int J Cancer (2009) 125. 2441-2449.
21. Baird SK, Aerts JL, Eddaoudi A, Lockley M, Lemoine NR and McNeish IA. Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer. Oncogene (2008) 27 3081-3090.
22. Botta G, Passaro C, Libertini S, Abagnale A, Barbato S, Maione AS, Hallden G, Beguinot F, Formisano P and Portella G. Inhibition of autophagy enhances the effects of E1A-defective oncolytic adenovirus dl922-947 against glioma cells in vitro and in vivo. Hum Gene Ther (2012) 23. 623-634.
23. Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, George MD, Klionsky DJ, Ohsumi M and Ohsumi Y. A protein conjugation system essential for autophagy. Nature (1998) 395. 395-398.
24. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T. Noda T, Kominami E, Ohsumi Y and Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J (2000) 19. 5720-5728.
25. Bjorkoy G, Lamark T, Brech A, Outzen H, PeranderM, Overvatn A. Stenmark H and Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on hun-tingtin-induced cell death. J Cell Biol (2005) 171. 603-614.
26. Rodriguez-Rocha H, Gomez-Gutierrez JG, Garcia-Garcia A, Rao XM, Chen L, McMasters KM and Zhou HS. Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology (2011)416. 9-15.
27. Bagchi S, Raychaudhuri P and Nevins JR. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor. a novel mechanism for E1A trans-activation. Cell (1990)62. 659-669.
28. Polager S, Ofir M and Ginsberg D. E2F1 regulates autophagy and the transcription of autophagy genes. Oncogene (2008) 27. 4860-4864.
29. Garcia-Garcia A, Rodriguez-Rocha H, Tseng MT, Montes de Oca-Luna R, Zhou HS, McMasters KM and Gomez-Gutierrez JG. E2F-1 lacking the transcriptional activity domain induces autophagy. Cancer Biol Ther (2012) 13. 1091-1101.
30. Kuroda S, Fujiwara T, Shirakawa Y, Yamasaki Y, Yano S, Uno F Tazawa H, Hashimoto Y, Watanabe Y, Noma K, Urata Y. Kagawa S and Fujiwara T. Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery. Cancer Res (2010) 70. 9339-9348.
31. Pyo JO, Jang MH, Kwon YK, Lee HJ, Jun Jl, Woo HN, Cho DH Choi B, Lee H, Kim JH, Mizushima N, Oshumi Y and Jung YK. Essential roles of Atg5 and FADD in autophagic cell death dissection of autophagic cell death into vacuole formation and eel death. J Biol Chem (2005) 280. 20722-20729.
32. O'Shea C, Klupsch K, Choi S, Bagus B, Soria C, Shen J. McCormick F and Stokoe D. Adenoviral proteins mimic nutrient/ growth signals to activate the mTOR pathway for viral replication. EMBO J (2005)24. 1211-1221.
33. Kim J, Kundu M, Viollet B and Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 Nat Cell Biol (2011) 13. 132-141.
34. Thomas MA, Broughton RS, Goodrum FD and Ornelles DA. E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus. J Virol (2009) 83. 2406-2416.
35. Camera E, Sutherland JD and Fortes P. Adenovirus and miRNAs. Biochim Biophys Acta (2011) 1809. 660-667.
36. Weber F, Wagner V, Kessler N and Haller O. Induction of interferon synthesis by the PKR-inhibitory VA RNAs of adenoviruses. J Interferon Cytokine Res (2006) 26. 1-7.
37. Yamaguchi T, Kawabata K, Kouyama E, Ishii KJ, Katayama K. Suzuki T, Kurachi S, Sakurai F, Akira S and Mizuguchi H. Induction of type I interferon by adenovirus-encoded small RNAs. Proc Natl Acad Sci U S A (2010) 107. 17286-17291
38. Minamitani T, Iwakiri D and Takada K. Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway. J Virol (2011) 85. 4035-4040.
39. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O and Akira S. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol (2005) 6. 981-988.
40. Thimmappaya B, Weinberger C, Schneider RJ and Shenk T. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell (1982) 31. 543-551
41. . Thimmappaya B and Shenk T. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced elF-2 alpha kinase. Cell (1986) 45. 195-200.
42. Aparicio O, Razquin N, Zaratiegui M, Narvaiza I and Fortes P Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production. J Virol (2006) 80. 1376-1384.
43. Kamel W, Segerman B, Oberg D, Punga T and Akusjarvi G. The adenovirus VA RNA-derived miRNAs are not essential for lytic virus growth in tissue culture cells. Nucleic Acids Res (2013) 41 4802-4812.
44. Wang Y, Xue SA, Hallden G, Francis J, Yuan M, Griffin BE and Lemoine NR. Virus-associated RNA l-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors. Cancer Res (2005)65. 1523-1531.
45. Cascallo M, GrosA, Bayo N, Serrano T, Capella G and Alemany R. Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses. Hum Gene Ther (2006) 17. 929-940.
46. Machitani M, Katayama K, Sakurai F, Matsui H, Yamaguchi T. Suzuki T, Miyoshi H, Kawabata K and Mizuguchi H. Development of an adenovirus vector lacking the expression of virus-associated RNAs. J Control Release (2011) 154. 285-289.
47. Su JL, Chen PB, Chen YH, Chen SC, Chang YW, Jan YH Cheng X, Hsiao M and Hung MC. Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Cancer Res (2010) 70. 5096-5108.
48. Baluchamy S, Sankar N, Navaraj A, Moran E and Thimmapaya B. Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction. Oncogene (2007) 26. 781-787.
49. Chakraborty AA and Tansey WP. Adenoviral E1A function through Myc. Cancer Res (2009) 69. 6-9.
50. Singhal G, Leo E, Setty SK, Pommier Y and Thimmapaya B. Adenovirus E1A Oncogene Induces Rereplication of Cellular DNA and Alters DNA Replication Dynamics. J Virol (2013) 87. 8767-8778.
51. Kolli S, Buchmann AM, Williams J, Weitzman S and Thimmapaya B. Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC. Proc Natl Acad Sci U S A (2001) 98. 4646-4651
52. Sankar N, Kadeppagari RK and Thimmapaya B. c-Myc-induced aberrant DNA synthesis and activation of DNA damage response in p300 knockdown cells. J Biol Chem (2009) 284. 15193-15205.
53. Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, Milne RS, Gotch F and Boshoff C. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol (2010) 12. 513-519.
54. Chiang K, Liu H and Rice AP. miR-132 enhances HIV-1 replication. Virology (2013) 438. 1-4.
55. Lee IH and Finkel T. Regulation of autophagy by the p300 acetyl-transferase. J Biol Chem (2009) 284. 6322-6328.
56. Tsuneoka M, Umata T, Kimura H, Koda Y, NakajimaM, Kosai K. Takahashi T, Takahashi Y and Yamamoto A. c-myc induces autophagy in rat 3Y1 fibroblast cells. Cell Struct Funct (2003) 28 195-204.
57. Lu S and Cullen BR. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J Virol (2004) 78 12868-12876
58. Andersson MG, Haasnoot PC, Xu N, Berenjian S, Berkhout B and Akusjarvi G. Suppression of RNA interference by adenovirus virus-associated RNA. J Virol (2005) 79. 9556-9565.
59. Xu N, Segerman B, Zhou X and Akusjarvi G. Adenovirus virus-associated RNAII-derived small RNAs are efficiently incorporated into the rna-induced silencing complex and associate with polyribosomes. J Virol (2007) 81. 10540-10549.
60. Sollerbrant K, Akusjarvi G and Svensson C. Repression of RNA polymerase III transcription by adenovirus E1A. J Virol (1993) 67 4195-4204.
61. Lize M, Pilarski S and Dobbelstein M. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ (2010) 17. 452-458.
62. Woods K, Thomson JM and Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem (2007) 282. 2130-2134.
63. Emmrich S and Putzer BM. Checks and balances. E2F-microRNA crosstalk in cancer control. Cell Cycle (2010) 9. 2555-2567.
64. Weihua Z, Tsan R, Huang WC, Wu Q, Chiu CH, Fidler IJ and Hung MC. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell (2008) 13. 385-393.
65. Wu YT, Tan HL, Huang Q, Ong CN and Shen HM. Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic eel death via suppression of autophagy. Autophagy (2009) 5. 824-834.
66. Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC and Holbrook NJ. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene (1997) 14. 929-935.
67. Fujiwara K, Daido S, Yamamoto A, Kobayashi R, Yokoyama T. Aoki H, Iwado E, Shinojima N, Kondo Y and Kondo S. Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy. J Biol Chem (2008) 283. 388-397.
68. Yamasaki Y, Tazawa H, Hashimoto Y, Kojima T, Kuroda S. Yano S, Yoshida R, Uno F, Mizuguchi H, Ohtsuru A, Urata Y. Kagawa S and Fujiwara T. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overex-pression through E1A-dependent p21 and MDM2 suppression. Eur J Cancer (2012) 48. 2282-2291.
69. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, lliopoulos D, Pilozzi E, Liu CG, Negrini M, Cavazzini L Volinia S, Alder H, Ruco LP, Baldassarre G, Croce CM and Vecchione A. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell (2008) 13. 272-286.
70. Wirth T, Kuhnel F, Fleischmann-Mundt B, Woller N, Djojosubroto M, Rudolph KL, Manns M, Zender L and Kubicka S. Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1. Cancer Res (2005) 65. 7393-7402.
71. You L, Wang Y, Jin Y and Qian W. Downregulation of Mcl-1 syn-ergizes the apoptotic response to combined treatment with cispla-tin and a novel fiber chimeric oncolytic adenovirus. Oncol Rep (2012)27. 971-978.
72. Ofir M, Hacohen D and Ginsberg D. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res (2011) 9. 440-447.
73. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan Rl, Alder H, Volinia S, Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M and Croce CM. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A (2008) 105. 5166-5171